HDFC Pharma and Healthcare Fund Regular Growth

+

Invest

Explore On

Equity
Sector - Healthcare
Rating N.A.
Plan

17.41 +0.10 (0.58%) NAV as on 17 Feb, 2026

5D
1M
6M
1Y
5Y
MAX

Key Metrics

AUM (in Cr)1983.91
CAGR 13.38%
Exit Load1.00%
Expense ratio2.10%
CategoryEquity
Min Investment100
Min SIP100
Launch Date2023-10-04

Asset Allocation

Holdings As On - 18 February 2026

Holdings

Sectors

Name
Value (Cr)
Holding %

Divi's Laboratories
160.69
8.57%

Lupin
122.34
6.52%

Alkem Laboratories
120.36
6.42%

IPCA Laboratories
93.73
5.00%

Anthem BioSciences
75.89
4.05%

Fortis Healthcare
71.72
3.82%

Peer Comparison

Fund Name
UTI Healthcare Fund Regular Plan Growth8.73%
Mirae Asset Healthcare Fund Regular Growth8.11%
Tata India Pharma & Healthcare Fund Regular Growth5.74%
DSP Healthcare Fund Regular Growth-0.26%
HDFC Pharma and Healthcare Fund Regular Growth13.38%

Risk & Volitility

Alpha 0.00%
Beta 0.00
Sharpe Ratio0.00
Std Deviation 0.00%
Tracking Error 0.00%

About Fund

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.

The HDFC Pharma and Healthcare Fund Regular Growth has an AUM of 1983.91 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 2.10%. The minimum investment in HDFC Pharma and Healthcare Fund Regular Growth is Rs 100 and the minimum SIP is Rs 100.

As per morningstar the risk & return rating of the fund are Medium & Low respectively.

The top holdings of the fund include Sun Pharmaceutical Industries, Divi's Laboratories, Glenmark Pharmaceuticals & Lupin.

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Chemical Manufacturing & Medical Equipment & Supplies.

Some of the similar funds are UTI Healthcare Fund Regular Plan Growth, Mirae Asset Healthcare Fund Regular Growth, Tata India Pharma & Healthcare Fund Regular Growth, DSP Healthcare Fund Regular Growth, HDFC Pharma and Healthcare Fund Regular Growth. HDFC Pharma and Healthcare Fund Regular Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.